💨 Abstract

iRadimed Corp. reported a net income of $5.8 million for the second quarter of 2025. The company achieved a profit of 45 cents per share, with adjusted earnings at 49 cents per share. Revenue was $20.4 million. For the third quarter, iRadimed anticipates earnings between 45 to 49 cents per share and revenue from $20.5 million to $20.9 million.

Courtesy: WTOP Staff